Have a personal or library account? Click to login
Bronchoscopic Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage-induced Acute Respiratory Failure in MPO-ANCA Vasculitis: A Case Report Cover

Bronchoscopic Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage-induced Acute Respiratory Failure in MPO-ANCA Vasculitis: A Case Report

The Journal of Critical Care Medicine
Volume 8 (2022): Issue 2 (April 2022)
By: Illaa Smesseim,  Titia Schaepman-Ruys,  Jan Willem Duitman,  Yosta Vegting,  Jorinde Raasveld,  Marc Hilhorst,  Alexander Vlaar,  Josien van Es and  Peter Bonta  
Open Access
|May 2022

Figures & Tables

Fig. 1

Plasma levels of D-dimer (red circles) and thrombin-antithrombin complexes (TATc; blue squares) 0, 1 and 24 hours upon first recombinant factor VIIa administration.
Plasma levels of D-dimer (red circles) and thrombin-antithrombin complexes (TATc; blue squares) 0, 1 and 24 hours upon first recombinant factor VIIa administration.
DOI: https://doi.org/10.2478/jccm-2022-0004 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 123 - 125
Submitted on: Jan 24, 2022
Accepted on: Apr 4, 2022
Published on: May 12, 2022
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
ARDS,
diffuse alveolar hemorrhage,
DAH,
novoseven,
vasculitis
Related subjects:
Medicine,
Clinical medicine,
Anaesthesiology,
Emergency medicine and intensive-care medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other

© 2022 Illaa Smesseim, Titia Schaepman-Ruys, Jan Willem Duitman, Yosta Vegting, Jorinde Raasveld, Marc Hilhorst, Alexander Vlaar, Josien van Es, Peter Bonta, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 8 (2022): Issue 2 (April 2022)Next article